Exploring Avenues Beyond Cell Therapies Is Imperative in 2024 to Unlock the Full Clinical Potential of NK Cells. The Innate Killer Summit is of paramount importance for attaining and assimilating insights from clinical advancements, instilling confidence in investors, and recognizing the potential of diverse therapies targeting natural killer (NK) cells. The necessity for collaborative endeavors within the community, encompassing collective brainstorming and data sharing, becomes critical as major companies optimize resources to prioritize clinical development.
